Guest 1: Pancreatic Action Network (PanCAN) and Halozyme
Lisa Kobzi, Media Relations Chair for the Pancreatic Action Network (PanCAN), is joined by Russell Gold, a pancreatic cancer survivor and Dr. Helen Torley, CEO of Halozyme, a San Diego biotech company focused on bringing a targeted treatment to pancreatic cancer. Kobzi chats about PanCAN’s recent PurpleStride San Diego Walk to End Pancreatic Cancer and Gold describes his experience as five-year pancreatic cancer survivor.

Guest 2: Duke University Center for Neurodegeneration and Neurotherapeutics
Dr. Al La Spada, Director of the Duke University Center for Neurodegeneration and Neurotherapeutics, talks about the growing epidemic of age-related neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. La Spada discusses the therapies the Center is developing for therapies and emerging research that will allow people to get tested and find out if they will develop a disease in the future.

1 Pancreatic Action Network (PanCAN) and Halozyme
2 Duke University Center for Neurodegeneration and Neurotherapeutics